BriaCell Therapeutics Corp. (BCTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous Close | 6.75 |
| Open | 6.82 |
| Bid | 6.70 x 1000 |
| Ask | 6.91 x 1000 |
| Day's Range | 6.61 - 7.01 |
| 52 Week Range | 4.06 - 12.09 |
| Volume | |
| Avg. Volume | 214,994 |
| Market Cap | 107.168M |
| Beta (5Y Monthly) | 1.70 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.29 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Baystreet
Stocks in play: BriaCell Therapeutics Corp
Has been selected to present four posters at the 2023 American Association for Cancer Research (AACR) ...
- GlobeNewswire
BriaCell to Present Clinical and Survival Data in Advanced Metastatic Breast Cancer at the 2023 AACR Annual Meeting
PHILADELPHIA and VANCOUVER, British Columbia, March 15, 2023 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, has been selected to present four posters at the 2023 American Association for Cancer Research (AACR) Annual Meeting held from April 14 - 19, 2023 at Orange County Convention Center, Orlando, Florida. The available abstract titles and
- Simply Wall St.
A BriaCell Therapeutics Corp. (TSE:BCT) insider increased their holdings by 20% last year
From what we can see, insiders were net buyers in BriaCell Therapeutics Corp.'s ( TSE:BCT ) during the past 12 months...
© 2023 Yahoo. All rights reserved.
